FDA Now Says New Alzheimer's Drug Should Have Limited Use. What Are the Implications?

The Food and Drug Administration is limiting the use of the drug Aduhelm to treat Alzheimer's disease. It's now being recommended only for people in the early stages of the disease. Medical professionals and officials at the Alzheimer's Association say they ...